• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,014
83
63
60
46

COUNTRY

58
19
10
7
5

CATEGORIES

  • 85
  • 124
  • 66
  • 65
  • 37
  • 37
  • 12
  • 12
  • 11
  • 18

PRICE

142
607
1,004
2,731

PUBLISHED

7
58
614
2,731

PRODUCT TYPE

2,619
90
12
7
1

Oncology

(2,731 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015 Summary This ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015’, provides an overview of the Metastatic...

February 2015
FROM

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy...

February 2015
FROM

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary This ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic...

February 2015
FROM

Chemotherapy Induced Anemia - Pipeline Review, H1 2015

Chemotherapy Induced Anemia - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

February 2015
FROM

Medullary Thyroid Cancer - Pipeline Review, H1 2015

Medullary Thyroid Cancer - Pipeline Review, H1 2015 Summary This ‘Medullary Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Medullary Thyroid Cancer’s therapeutic pipeline. This...

February 2015
FROM

Sezary Syndrome Global Clinical Trials Review, H1, 2015

Sezary Syndrome Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Sezary Syndrome clinical...

February 2015
FROM

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1,...

February 2015
FROM

Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2015

Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2015" provides data on the Non-Rhabdomyosarcoma...

February 2015
FROM

Liposarcoma Global Clinical Trials Review, H1, 2015

Liposarcoma Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Liposarcoma clinical trial...

February 2015
FROM

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015" provides data on...

February 2015
FROM

Bone Metastasis Global Clinical Trials Review, H1, 2015

Bone Metastasis Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2015" provides data on the Bone Metastasis clinical...

February 2015
FROM

Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer...

February 2015
FROM

Anal Cancer - Pipeline Review, H1 2015

Anal Cancer - Pipeline Review, H1 2015 Summary This, ‘Anal Cancer - Pipeline Review, H1 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline. This report provides comprehensive information...

February 2015
FROM

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Acute Lymphoblastic Lymphoma’s therapeutic...

February 2015
FROM
Xeloda-Drug Insights,2014 Xeloda-Drug Insights,2014 - Product Thumbnail Image

Xeloda-Drug Insights,2014

“Xeloda - Drug Insights, 2014” provides Xeloda marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

February 2015
FROM
Tarceva-Drug Insights,2014 Tarceva-Drug Insights,2014 - Product Thumbnail Image

Tarceva-Drug Insights,2014

“Tarceva - Drug Insights, 2014” provides Tarceva marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Tyverb-Drug Insights,2014 Tyverb-Drug Insights,2014 - Product Thumbnail Image

Tyverb-Drug Insights,2014

“Tyverb - Drug Insights, 2014” provides Tyverb marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

February 2015
FROM
Gemzar-Drug Insights,2014 Gemzar-Drug Insights,2014 - Product Thumbnail Image

Gemzar-Drug Insights,2014

“Gemzar - Drug Insights, 2014” provides Gemzar marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical...

February 2015
FROM
Votrient-Drug Insights,2014 Votrient-Drug Insights,2014 - Product Thumbnail Image

Votrient-Drug Insights,2014

“Votrient - Drug Insights, 2014” provides Votrient marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Loxifan-Drug Insights,2014 Loxifan-Drug Insights,2014 - Product Thumbnail Image

Loxifan-Drug Insights,2014

“Loxifan - Drug Insights, 2014” provides Loxifan marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)